Access cutting-edge lung cancer treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Fresno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer. People can join the study if they have tumours with HER2 mutations and have not yet received any systemic therapy including chemotherapy for advanced or metastatic lung cancer. The purpose of this study is to find out whether a medicine called zongertinib (BI 1810631) can slow down the worsening of advanced non-small cell lung cancer better than the standard treatment available. Zongertinib ma
Sponsor: Boehringer Ingelheim
Check if you qualify for this lung cancer clinical trial in Fresno, CA
If you're searching for lung cancer treatment options in Fresno, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.